Final Analysis of Pfizer's Vaccine Trials Even Better

Final analysis of late-stage trials shows it's 95% effective, with no major safety worries
Posted Nov 18, 2020 6:48 AM CST
More News: Entertainment | Tech | Business | Politics | Health